|
Volumn 80, Issue 5, 2003, Pages 1100-1104
|
Methodologic pitfalls in assessing the efficacy of recombinant follicle-stimulating hormone versus human menopausal gonadotropin in assisted reproduction
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GONADORELIN AGONIST;
HUMAN MENOPAUSAL GONADOTROPIN;
RECOMBINANT FOLLITROPIN;
AGE DISTRIBUTION;
CLINICAL PRACTICE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MANUFACTURE;
DRUG PURITY;
EMBRYO TRANSFER;
EVALUATION;
FEMALE INFERTILITY;
FOLLITROPIN BLOOD LEVEL;
HORMONE ACTION;
HORMONE URINE LEVEL;
HUMAN;
INFERTILITY THERAPY;
LOGISTIC REGRESSION ANALYSIS;
LUTEAL PHASE;
LUTEINIZING HORMONE BLOOD LEVEL;
META ANALYSIS;
NONHUMAN;
OUTCOMES RESEARCH;
OVARY HYPERSTIMULATION;
PREGNANCY RATE;
PRIORITY JOURNAL;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
RELIABILITY;
REVIEW;
STATISTICAL SIGNIFICANCE;
STRATIFICATION;
|
EID: 0242713034
PISSN: 00150282
EISSN: None
Source Type: Journal
DOI: 10.1016/S0015-0282(03)02193-9 Document Type: Note |
Times cited : (12)
|
References (8)
|